Skip to main content
Home Start-Ups

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2024/12/humacyte-logo-new.png

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Humacyte is a Duke University start-up out of the lab of Dr. Laura Niklason (formerly Anesthesiology, SOM), co-founded with Drs. Juliana Blum and Shannon Dahl.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/TUSW-Dec-2024-featured-image-v3.jpeg

Duke, UNC, and NC State academics get crash course in building startups

Faculty and students with promising IP developed at Triangle universities were invited to workshop their ideas with the help of serial entrepreneurs.

Read More

https://otc.duke.edu/wp-content/uploads/2024/11/1.-Invented-at-Duke-2024-featured-image.jpeg

Invented at Duke 2024 showcases the past and present of innovation at Duke, promising a bright future

A special Centennial edition of Invented at Duke featured inventors and innovations from the past, present, and future of Duke.

Read More

https://otc.duke.edu/wp-content/uploads/2024/11/dannce-horizontal.png

DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care

DANNCE.ai, a start-up from the lab of Assistant Professor Timothy Dunn (BME, Pratt), is also in the Duke Capital Partners portfolio.

Read More

https://otc.duke.edu/wp-content/uploads/2024/11/Satellite-New-DT-Magazine-Hero-53-7.jpg

New Frontiers in Space

Satellite antenna can take images faster and more often than existing technology, allowing us to track the Earth as it evolves. Extellis is an inventor booth at Invented at Duke 2024.

Read More

https://otc.duke.edu/wp-content/uploads/2022/09/Tune-TherapeuticsTune-Therapeutics.jpeg

Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B

Tune Therapeutics is a Duke University start-up and Duke Capital Partners portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2024/11/Injecting-Hope-New-DT-Magazine-Hero-53-5.jpg

Injecting Hope

Researchers say injectable gel-like substance has healing powers for bone injuries. OsteoCure is an inventor booth at Invented at Duke 2024.

Read More

https://otc.duke.edu/wp-content/uploads/2024/10/Triangle-Venture-Day-badge-IMG_7088.jpg

Early-stage startups meet potential investors, partners at Triangle Venture Day

A total of 20 Triangle startups – including 4 with Duke roots – pitched their ideas to an audience that included more than 50 investor and strategic partnership groups at the Raleigh Convention Center.

Read More

https://otc.duke.edu/wp-content/uploads/2024/10/entrepreneurs-1536x1051-1.jpg

The Hard-Earned Lessons of Academic Entrepreneurs

Pratt I/O Magazine – Faculty entrepreneurs from Duke Engineering share their experiences of what it takes to spin a startup out of a university.

Read More

1 2 3 35